ATYR aTyr Pharma Inc Net earnings per share growth forecast for next year
aTyr Pharma, Inc. (ATYR) is implementing breakthrough immune modulation methods to combat fibrosis and rare sarcoidosis. The expected EPS growth rate for the coming year helps assess the asset's fair value, where the value 39.30 describes the current level. Cost optimization through outsourced trials maintains team flexibility, while the upcoming Phase 3 trial results will serve as a key growth driver.
Financial and market metric breakdowns for aTyr (ATYR)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio aTyr Pharma, Inc.|ATYR - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio atyrpharma.com|ATYR - Company Cumulative Debt|Debt to Book Capitalization Ratio aTyr|ATYR - Company Long-Term Loans and Borrowings|Company Current Liabilities aTyr Pharma|Quick Liquidity atyrpharma.com
- earnings and valuation multiples information:
ATYR - Profit After Tax|Projected Future Earnings aTyr Pharma, Inc.|ATYR - Company Value to Net Income|Forward P/E Multiple atyrpharma.com|ATYR - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization aTyr|ATYR - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months aTyr Pharma|ATYR - Net earnings per share for the last 12 months|Quarterly EPS earnings growth atyrpharma.com|ATYR - Earnings growth in current year|Expected earnings per share growth for next year aTyr Pharma, Inc.
- total revenue and sales volume data:
Fundamental company analysis:ATYR, aTyr Pharma, Inc.
This indicator measures the expected earnings per share (EPS) dynamics for the next period, reflecting the analysts' consensus forecast for business growth rates. Professional investors utilize current expectations for the EPS n+1 growth rate to assess the sustainability of capitalization against changing market conditions. For aTyr Pharma, Inc. (ATYR), this trend is critically important as it reflects market confidence in the success of its unique developments amidst fierce competition with biotech behemoths.
Competitor analysis for aTyr Pharma, Inc.
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|ADAG - Expected earnings per share growth for next year|IMA - Net earnings per share growth forecast for next year|Shattuck Labs - Projected earnings per share increase next year|EQ: Earnings growth forecast for next year|Net earnings per share change forecast for next year CNTB (Connect Biopharma Holdings)|Expected earnings per share growth for next year IMUX|ATRA (atarabio.com) - Projected earnings per share increase next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharma (XFOR)|Adicet Bio Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year celularity.com CELU|INMB: Expected earnings per share growth for next year|BRNS: Net earnings per share growth forecast for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc - Expected earnings per share trend next year|AKTX (Akari Therapeutics, Plc) - Earnings growth forecast for next year|ENLV: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Q32 Bio (QTTB)|Expected earnings per share growth for next year GeoVax Labs GOVX|Earnings growth forecast for next year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Expected net earnings per share growth next year|CARM: Expected earnings per share growth for next year|XTL Biopharmaceuticals (XTLB) - Expected earnings per share growth for next year|BOLT: Earnings growth forecast for next year|Expected earnings per share growth for next year HCW Biologics Inc.|Net earnings per share growth forecast for next year aptevotherapeutics.com|AIM: Expected earnings per share trend next year|Net earnings per share growth forecast for next year aditxt.com (ADTX)|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Expected net earnings per share growth next year|REVB - Net earnings per share growth forecast for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
